Premium
Exosomes and other extracellular vesicles in oral and salivary gland cancers
Author(s) -
Zhan Chaoning,
Yang Xiaojun,
Yin Xuemin,
Hou Jin
Publication year - 2020
Publication title -
oral diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.953
H-Index - 87
eISSN - 1601-0825
pISSN - 1354-523X
DOI - 10.1111/odi.13172
Subject(s) - microvesicles , microrna , angiogenesis , exosome , biology , microbiology and biotechnology , tumor microenvironment , extracellular vesicle , metastasis , cell , cancer research , cancer , tumor progression , cancer cell , gene , genetics
Extracellular vesicles (EVs, including exosomes) are a group of heterogeneous nanometer‐sized vesicles that are released by all types of cells and serve as functional mediators of cell‐to‐cell communication. This ability is primarily due to their capacity to package and transport various proteins, lipids, and nucleic acids—namely DNA and messenger RNA (mRNA), but also microRNAs (miRNAs) and long non‐coding RNAs (lncRNAs). These contents can influence the function and fate of both recipient and donor cells. More and more studies have shown that EVs are involved in every phase of cancer development, mediating bidirectional cross talk between cancer cells and their tissue microenvironment. More specifically, EVs can promote tumor progression by modifying vesicular contents and establishing a distant premetastatic niche with molecules that favor cancer cell proliferation, migration, invasion, metastasis, angiogenesis, and even drug resistance. Given that the packaging of these molecules is known to be tissue‐specific, EVs can not only serve as novel prognostic and diagnostic markers but also be used as potential therapeutic targets and vehicles for drug delivery. The present review discusses the current understanding of the multifaceted roles of EVs in the progression of oral and salivary gland cancers, as well as their potential use in clinical applications.